Monte Rosa Therapeutics’ $222.3 Million Initial Public Offering

Latham & Watkins LLP represented the underwriters in the offering.Monte Rosa Therapeutics, Inc. executed its initial public offering of 11,700,000 shares of common stock at a public…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:
Martina Bellini

Author: Martina Bellini

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here